1,1-Dioxo-5,6-dihydro-[4,1,2]oxathiazines, a novel class of 11β-HSD1 inhibitors for the treatment of diabetes - Böhme, T; Engel, C K; Farjot, G; Güssregen, S; Haack, T; Tschank, G; Ritter, K (Bioorg Med Chem Lett, 2013)